119 related articles for article (PubMed ID: 28374040)
1. Selenadiazole derivatives antagonize hyperglycemia-induced drug resistance in breast cancer cells by activation of AMPK pathways.
Zhao J; Zeng D; Liu Y; Luo Y; Ji S; Li X; Chen T
Metallomics; 2017 May; 9(5):535-545. PubMed ID: 28374040
[TBL] [Abstract][Full Text] [Related]
2. Rational design of selenadiazole derivatives to antagonize hyperglycemia-induced drug resistance in cancer cells.
Liu Y; Luo Y; Li X; Zheng W; Chen T
Chem Asian J; 2015 Mar; 10(3):642-52. PubMed ID: 25641920
[TBL] [Abstract][Full Text] [Related]
3. Microwave-Assisted Syntheses of Benzimidazole-Containing Selenadiazole Derivatives That Induce Cell-Cycle Arrest and Apoptosis in Human Breast Cancer Cells by Activation of the ROS/AKT Pathway.
Liang Y; Zhou Y; Deng S; Chen T
ChemMedChem; 2016 Oct; 11(20):2339-2346. PubMed ID: 27677422
[TBL] [Abstract][Full Text] [Related]
4. Highly stable selenadiazole derivatives induce bladder cancer cell apoptosis and inhibit cell migration and invasion through the activation of ROS-mediated signaling pathways.
Yang Y; Deng S; Zeng Q; Hu W; Chen T
Dalton Trans; 2016 Nov; 45(46):18465-18475. PubMed ID: 27711726
[TBL] [Abstract][Full Text] [Related]
5. Selenadiazole Derivatives Inhibit Angiogenesis-Mediated Human Breast Tumor Growth by Suppressing the VEGFR2-Mediated ERK and AKT Signaling Pathways.
Lai H; Fu X; Sang C; Hou L; Feng P; Li X; Chen T
Chem Asian J; 2018 Jun; 13(11):1447-1457. PubMed ID: 29575811
[TBL] [Abstract][Full Text] [Related]
6. Caspase- and p53-dependent apoptosis in breast carcinoma cells induced by a synthetic selenadiazole derivative.
Chen T; Wong YS; Zheng W; Liu J
Chem Biol Interact; 2009 Jun; 180(1):54-60. PubMed ID: 19146838
[TBL] [Abstract][Full Text] [Related]
7. Furanodiene alters mitochondrial function in doxorubicin-resistant MCF-7 human breast cancer cells in an AMPK-dependent manner.
Zhong ZF; Tan W; Qiang WW; Scofield VL; Tian K; Wang CM; Qiang WA; Wang YT
Mol Biosyst; 2016 Apr; 12(5):1626-37. PubMed ID: 26987443
[TBL] [Abstract][Full Text] [Related]
8. Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin.
Xue C; Wang C; Sun Y; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Ma X; Peng J; Liu K
Oncotarget; 2017 Jan; 8(5):8622-8632. PubMed ID: 28052008
[TBL] [Abstract][Full Text] [Related]
9. Sensitization of cancer cells to radiation by selenadiazole derivatives by regulation of ROS-mediated DNA damage and ERK and AKT pathways.
Xie Q; Zhou Y; Lan G; Yang L; Zheng W; Liang Y; Chen T
Biochem Biophys Res Commun; 2014 Jun; 449(1):88-93. PubMed ID: 24813998
[TBL] [Abstract][Full Text] [Related]
10. Novel selenadiazole derivatives as selective antitumor and radical scavenging agents.
Ruberte AC; Plano D; Encío I; Aydillo C; Sharma AK; Sanmartín C
Eur J Med Chem; 2018 Sep; 157():14-27. PubMed ID: 30071406
[TBL] [Abstract][Full Text] [Related]
11. Dual-targeting hybrid peptide-conjugated doxorubicin for drug resistance reversal in breast cancer.
Sheng Y; You Y; Chen Y
Int J Pharm; 2016 Oct; 512(1):1-13. PubMed ID: 27521706
[TBL] [Abstract][Full Text] [Related]
12. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss.
Zhong T; Xu F; Xu J; Liu L; Chen Y
Biomed Pharmacother; 2015 Feb; 69():317-25. PubMed ID: 25661377
[TBL] [Abstract][Full Text] [Related]
13. NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.
Velaei K; Samadi N; Soltani S; Barazvan B; Soleimani Rad J
Breast Cancer; 2017 Jul; 24(4):552-561. PubMed ID: 27878697
[TBL] [Abstract][Full Text] [Related]
14. Isorhamnetin induces cell cycle arrest and apoptosis by triggering DNA damage and regulating the AMPK/mTOR/p70S6K signaling pathway in doxorubicin-resistant breast cancer.
Yang T; Xiao Y; Liu S; Luo F; Tang D; Yu Y; Xie Y
Phytomedicine; 2023 Jun; 114():154780. PubMed ID: 37004402
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
Zeng X; Morgenstern R; Nyström AM
Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
[TBL] [Abstract][Full Text] [Related]
16. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
Zhang ZL; Jiang QC; Wang SR
Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
[TBL] [Abstract][Full Text] [Related]
17. Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance.
Wang H; Yin H; Yan F; Sun M; Du L; Peng W; Li Q; Feng Y; Zhou Y
Oncotarget; 2015 Feb; 6(5):2827-42. PubMed ID: 25605018
[TBL] [Abstract][Full Text] [Related]
18. The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling.
Scherbakov AM; Sorokin DV; Tatarskiy VV; Prokhorov NS; Semina SE; Berstein LM; Krasil'nikov MA
IUBMB Life; 2016 Apr; 68(4):281-92. PubMed ID: 26892736
[TBL] [Abstract][Full Text] [Related]
19. Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics.
Chekhun VF; Borikun TV; Lukianova NY
Exp Oncol; 2016 Mar; 38(1):26-30. PubMed ID: 27031715
[TBL] [Abstract][Full Text] [Related]
20. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ0814061), a novel microtubule inhibitor, evokes G2/M cell cycle arrest and apoptosis in human breast cancer cells.
Xu J; Zuo D; Qi H; Shen Q; Bai Z; Han M; Li Z; Zhang W; Wu Y
Biomed Pharmacother; 2016 Mar; 78():308-321. PubMed ID: 26898456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
